Ipilimumab vs Metronidazole
Ipilimumab vs Metronidazole: Overview
This comparison examines the pharmacological differences between Ipilimumab and Metronidazole.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Metronidazole β 8 hours.
Chemical Properties
Molecular Formula: Metronidazole β C6H9N3O3.
Molecular Weight: Metronidazole β 171.1540 g/mol.
Type: Ipilimumab β Antibody; Metronidazole β Small molecule.